Tag Archives: MACK

Top 10 Casino Stocks To Own Right Now

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It’s completely free and we guarantee you’ll learn something new every day.

Private equity firms have amassed sizable stakes in countless glamorous businesses, from casinos lining the Vegas strip to professional sports teams. But some of the most alluring investments come from everyday places.

PE industry stalwart Blackstone Group has just agreed to buy the family owned Chamberlain Group parent of top-of-the-line garage door opener purveyor, LiftMaster. The Wall Street Journal reported news of the deal Tuesday, which values the company at roughly $5 billion including debt.

Garage Brand

While arguably not as hip as some of Blackstone’s digital investments like dating app suite Bumble or family history service Ancestry, Illinois-based Chamberlain’s garage door openers are relied on by millions of homes and businesses worldwide.

Owner of the LiftMaster, Chamberlain, Grifco, and Merlin brands, the firm’s myQ platform grants users garage door control via an app, useful for remote acceptance of food and grocery deliveries or to simply let the pet out for a stroll. And a partnership with Amazon launched in 2019 offers Prime customers in select cities packages delivered securely right into their garages. With a business model as reliable and adaptive as Chamberlain’s, Blackstone wants in for the long haul:

Top 10 Casino Stocks To Own Right Now: Textainer Group Holdings Limited(TGH)

Textainer Group Holdings Limited (TGH), incorporated on December 2, 1993, is a holding company. The Company is involved in the purchase, ownership, management, leasing and disposal of a fleet of intermodal containers. The Company operates in three segments: Container Ownership, which owned containers accounting for approximately 80% of the Company’s fleet; Container Management, which managed containers on behalf of approximately 10 affiliated and unaffiliated container investors, providing acquisition, management and disposal services, and total managed containers accounted for approximately 20% of its fleet, and Container Resale, which sells containers from its fleet when they reach the end of their useful lives in marine service, and also purchases and leases or resells containers from shipping line customers, container traders and other sellers of containers. The Company is a lessor of intermodal containers based on fleet size, with a total fleet of approximately 2.1 million containers. The Company leases containers to approximately 360 shipping lines and other lessees. The Company is also a seller of used containers.

The Company’s subsidiaries include Textainer Equipment Management Limited (TEML), which provides container management, acquisition and disposal services to affiliated and unaffiliated container investors, and Textainer Limited (TL), which owns containers directly and through its subsidiaries, which include Textainer Marine Containers II Limited (TMCL II), Textainer Marine Containers III Limited (TMCL III), Textainer Marine Containers IV Limited (TMCL IV), TAP Funding Ltd. (TAP Funding) and TW Container Leasing Ltd. (TW). The Company leases containers under different types of leases, which include term leases, master leases, finance leases and spot leases. Term leases provide a customer with a specified number of containers for a specified period of time ranging from 3 to 5 years, with an associated set of pick-up and drop-off conditions. Term leases also include lifecycle! leases, under which lessees will lease containers until they reach a pre-specified age, which is near the end of their useful lives. Master leases provide a framework of terms and conditions valid for a specified period of time, typically one year. Finance leases, which provide customers an alternative means for purchasing containers. Spot leases, which provide customers with containers for a relatively short lease period and fixed pick-up and drop-off locations.

The Company operates its business through a network of regional and area offices and independent depots. The Company maintains approximately four regional offices: Americas Region in Hackensack, New Jersey, the United States responsible for North and South America; European Region in New Malden, the United Kingdom responsible for Europe, the Mediterranean, the Middle East and Africa; North Asia Region in Yokohama, Japan responsible for Japan, South Korea and Taiwan, and South Asia Region in Singapore, responsible for Southeast Asia, the People’s Republic of China (PRC), including Hong Kong and Australia. The Company operates approximately 3,147,690 twenty foot equivalent unit (TEU).

The Company competes with Leased Assets Pool Company Limited.

Advisors’ Opinion:

  • [By Joseph Griffin]

    ValuEngine cut shares of Textainer Group (NYSE:TGH) from a sell rating to a strong sell rating in a research note released on Wednesday morning.

    Several other equities research analysts have also commented on the company. Zacks Investment Research lowered Textainer Group from a buy rating to a hold rating in a research note on Wednesday, April 25th. Compass Point started coverage on Textainer Group in a research note on Monday, April 23rd. They set a neutral rating and a $17.00 price target on the stock. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the company’s stock. The company presently has an average rating of Hold and a consensus target price of $20.67.

  • [By Matthew DiLallo]

    Last year was one that investors in Textainer Group Holdings (NYSE:TGH) will likely remember fondly as the container leasing company’s stock rocketed an eye-popping 188%. This year, however, has been a different story as shares are down nearly 30% since the beginning of the year, and more than 40% off their high. That sell-off might have investors wondering if now’s a good time to buy.

Top 10 Casino Stocks To Own Right Now: Berkshire Hills Bancorp, Inc.(BHLB)

Berkshire Hills Bancorp, Inc. provides retail and commercial banking, wealth management and investment, and insurance services. The company operates through two segments, Banking and Insurance. It offers various deposit accounts, including interest-bearing and noninterest-bearing checking demand, regular savings, money market savings, time certificates of deposit, and retirement deposit accounts; and loans, such as residential mortgages, commercial real estate, commercial and industrial, and consumer loans. The company also provides wealth management services comprising investment management, trust administration, and estate planning; and investment products, financial planning, and brokerage services. In addition, it offers personal and commercial property, and casualty insurance; employee benefits insurance; and life, health, and financial services insurance products. Further, the company provides retail and commercial electronic banking, commercial cash management, and commercial interest rate swaps; and debit cards and other electronic fee producing payment services to transaction account customers. It serves retail, commercial, not-for-profit, and municipal customers. The company operates 91 full-service banking offices in Massachusetts, New York, Connecticut, and Vermont; and commercial and retail lending offices located in eastern Massachusetts. Berkshire Hills Bancorp, Inc. was founded in 1846 and is headquartered in Pittsfield, Massachusetts.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Berkshire Hills Bancorp, Inc. (NYSE:BHLB) – Jefferies Financial Group issued their Q2 2019 earnings per share estimates for shares of Berkshire Hills Bancorp in a research report issued to clients and investors on Tuesday, October 9th. Jefferies Financial Group analyst C. Haire forecasts that the savings and loans company will post earnings of $0.75 per share for the quarter. Jefferies Financial Group also issued estimates for Berkshire Hills Bancorp’s Q3 2019 earnings at $0.80 EPS, Q4 2019 earnings at $0.77 EPS and FY2020 earnings at $3.13 EPS.

  • [By Ethan Ryder]

    Berkshire Hills Bancorp, Inc. (NYSE:BHLB) has been given a consensus rating of “Hold” by the ten research firms that are currently covering the firm, Marketbeat reports. Nine research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $40.00.

  • [By Joseph Griffin]

    Berkshire Hills Bancorp (NYSE: BHLB) and Southern Missouri Bancorp (NASDAQ:SMBC) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, risk, valuation and institutional ownership.

Top 10 Casino Stocks To Own Right Now: Cogentix Medical, Inc.(CGNT)

Cogentix Medical, Inc., formerly Vision-Sciences, Inc., incorporated on October 19, 1987, is a medical device company. The Company designs, develops, manufactures and markets products for endoscopy with its product lines featuring a visualization system and sterile disposable microbial barrier, EndoSheath technology, providing users with endoscope turnover. The Company produces and markets Endoscopes (cystoscopes, ureteroscopes, laryngoscopes, otoscopes, sinuscopes, trans-nasal esophagoscopy (TNE) and bronchoscopes for medical use, and borescopes for industrial use) and digital processing units (DPU); EndoSheath technology; Urgent PC System; Macroplastique, and other products and applications.

Endoscopes and Digital Processing Units for Medical Use

The Company developed two visualization platforms for endoscopy: fiber optic (4000 Series) and video (5000 Series and 7000 Series). Its 4000 Series fiberscopes contain fiber optic imaging systems with functional aspects, such as small diameter endoscopes and portability options, through the use of a battery-powered light source. Its digital video-based endoscopes facilitate diagnostic and therapeutic procedures. Its diameter videoscopes contain a charge-coupled device (CCD) camera at the tip of the scope, offering a sharp, vibrant, full screen image. The 7000 Series and 5000 Series video endoscopes also feature functional aspects, including the elimination of an external light source, the inclusion of an integrated light emitting diode (LED), small diameter sizes and durability. Its 7000 Series and 5000 Series videoscopes are powered by its multi-functional digital processing unit (DPU). Within the Urology market, the Company developed products for urology with its fiber and video cystoscopes, both utilizing its EndoSheath technology. It also developed a video-based flexible ureteroscope, which gives surgeons unsurpassed visualization of the ureters and kidneys with up to 240 degrees of articulation allowing access to the areas of ! the kidney. It manufactures and markets fiber and video laryngoscopes and borescopes.

EndoSheath Technology

EndoSheath technology allows the healthcare practitioner to install the EndoSheath disposable onto the endoscope. In addition, its EndoSheath technology has an optically clear window that fits over the endoscope tip, providing a clear image. EndoSheath technology offers various-size working channels, unlike conventional flexible endoscopes, which have the working channel inside the endoscope itself, allowing its users to customize the scope to the procedure (diagnostic cystoscopy, which requires a small working channel, or therapeutic cystoscopy, which requires a larger working channel). Within the Urology market, the Company offers urologists two sheath models for each of its fiber and video cystoscopes: a diagnostic sheath with a 1.5 millimeter working channel size and a therapeutic sheath with a 2.1 millimeter working channel size. Within the TNE market, the Company markets and distributes two sheath models for its video TNE endoscope: a diagnostic sheath with a 1.5 millimeter working channel size and a therapeutic sheath with a 2.1 millimeter working channel size. Within the Pulmonology market, the Company markets and distributes four sheath models for video and fiber bronchoscopy: a 1.5 millimeter working channel, a 2.1 millimeter working channel, a 2.8 millimeter working channel (available outside of the United States only) and one without a working channel.

Urgent PC Systems

The Company’s Urgent PC System is a nerve stimulation device designed for office-based treatment of overactive bladder (OAB) and the associated symptoms of urge incontinence, urinary urgency and urinary frequency. Using a small-gauge needle electrode inserted above the ankle, the Company’s Urgent PC System delivers electrical impulses to the tibial nerve that affect the sacral nerve plexus, a control center for pelvic floor and bladder function. Urgent PC System treatm! ents offe! r an alternative to the invasive treatments, such as surgery, implantation of a sacral nerve stimulation device or injection of OnabotulinumtoxinA, a prescription drug marketed under the name of BOTOX, into the bladder.

Macroplastique

The Company’s Macroplastique is an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency (ISD). Macroplastique is a permanent implant injected, under endoscopic visualization, around the urethra distal to the bladder neck. It is a composition of heat vulcanized, solid, soft, irregularly shaped polydimethylsiloxane (solid silicone elastomer) implants suspended in a biocompatible excretable carrier gel.

Other Products and Applications

The Company also provides and markets additional products and applications, such as Macroplastique for Vesicoureteral Reflux, PTQ Implants, Urgent PC for Fecal Incontinence and VOX Implants. The Macroplastique products are used for treatment of vesicoureteral reflux – the abnormal backflow of urine from the bladder into the ureters or kidneys. PTQ Implants offer permanent implant for treatment of fecal incontinence. VOX Implants are used for vocal cord rehabilitation applications. The Company distributes certain wound care products in The Netherlands and the United Kingdom.

The Company competes with Olympus, Pentax, Karl Storz Industrial, Lenox, Pfizer Inc., Johnson & Johnson, Novartis AG, Allergan, Inc., GlaxoSmithKline plc, Carbon Medical Technologies, Inc., Merz Aesthetics, Inc., Galderma S.A. and Contura, Inc.

Advisors’ Opinion:

  • [By Joseph Griffin]

    Aradigm (NASDAQ:ARDM) and Vision Sciences (NASDAQ:CGNT) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst recommendations, earnings and institutional ownership.

  • [By Joseph Griffin]

    News coverage about Vision Sciences (NASDAQ:CGNT) has trended somewhat positive on Friday, Accern reports. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Vision Sciences earned a coverage optimism score of 0.19 on Accern’s scale. Accern also gave news headlines about the medical device company an impact score of 43.7920504117832 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 Casino Stocks To Own Right Now: MDU Resources Group, Inc.(MDU)

MDU Resources Group, Inc., incorporated on March 14, 1924, is a diversified natural resource company. The Companys segments include Electric, Natural Gas Distribution, Pipeline and Midstream, Construction Materials and Contracting, Construction Services and Refining. Montana-Dakota Utilities Co. (Montana-Dakota) is a public utility division of the Company. Montana-Dakota, through the electric and natural gas distribution segments, generates, transmits and distributes electricity and distributes natural gas in Montana, North Dakota, South Dakota and Wyoming. The Company, through Cascade Natural Gas Corporation (Cascade) distributes natural gas in Oregon and Washington. The Company, through Intermountain Gas Company (Intermountain) distributes natural gas in Idaho. Great Plains Natural Gas Co. (Great Plains) is a public utility division of the Company. Great Plains distributes natural gas in western Minnesota and southeastern North Dakota.

The Company, through its subsidiary, Centennial Energy Holdings, Inc. (Centennial), owns WBI Holdings, Inc. (WBI Holdings), which consists of the pipeline and midstream. Knife River is the construction materials and contracting segment, MDU Construction Services Group, Inc. (MDU Construction Services) consists of construction services segment, and Centennial Energy Resources LLC (Centennial Resources) and Centennial Holdings Capital LLC (Centennial Capital) are both reflected in the other category. The Company produces greenhouse gas (GHG) emissions from its fossil fuel electric generating facilities, as well as from natural gas pipeline and storage systems, operations of equipment and fleet vehicles, and oil and natural gas exploration and development activities.

Electric

Montana-Dakota provides electric service at retail, serving over 142,000 residential, commercial, industrial and municipal customers in approximately 180 communities. The properties owned by Montana-Dakota for use in its electric operations include interests! in over 10 electric generating facilities and approximately three small portable diesel generators, approximately 3,100 and 5,000 miles of transmission and distribution lines, respectively, and over 70 transmission and approximately 320 distribution substations. Montana-Dakota has obtained and holds, or is in the process of renewing, valid and existing franchises authorizing it to conduct its electric operations in all of the municipalities it serves where such franchises are required. Through Midcontinent Independent System Operator, Inc. (MISO), Montana-Dakota has access to wholesale energy, ancillary services and capacity markets for its integrated system. MISO is a regional transmission organization responsible for operational control of the transmission systems of its members. MISO provides security center operations, tariff administration and operates day-ahead and real-time energy markets, ancillary services and capacity markets. As a member of MISO, Montana-Dakota’s generation is sold into the MISO energy market and its energy needs are purchased from that market. Through an interconnected electric system, Montana-Dakota serves markets in portions of western North Dakota, including Bismarck, Mandan, Dickinson, Williston and Watford City; eastern Montana, including Sidney, Glendive and Miles City, and northern South Dakota, including Mobridge. Montana-Dakota’s interconnected system electric generating capability includes approximately four steam-turbine generating units using coal for fuel, approximately three combustion turbine peaking stations, approximately three wind electric generating facilities, a reciprocating internal combustion engine, a heat recovery electric generating facility and approximately three small portable diesel generators.

Natural Gas Distribution

The Company’s natural gas distribution operations consist of Montana-Dakota, Great Plains, Cascade and Intermountain, which sell natural gas at retail, serving over 906,000 residential, commercial and i! ndustrial! customers in over 330 communities and adjacent rural areas, and provides natural gas transportation services to certain customers on their systems. These services are provided through distribution systems aggregating approximately 19,100 miles. The natural gas distribution operations have obtained and hold, or are in the process of renewing, valid and existing franchises authorizing them to conduct their natural gas operations in all of the municipalities they serve, where such franchises are required.

The natural gas distribution operations serve retail natural gas markets, consisting primarily of residential and firm commercial space and water heating users, in portions of Idaho, including Boise, Nampa, Twin Falls, Pocatello and Idaho Falls; western Minnesota, including Fergus Falls, Marshall and Crookston; eastern Montana, including Billings, Glendive and Miles City; North Dakota, including Bismarck, Mandan, Dickinson, Wahpeton, Williston, Watford City, Minot and Jamestown; central and eastern Oregon, including Bend, Pendleton, Ontario and Baker City; western and north-central South Dakota, including Rapid City, Pierre, Spearfish and Mobridge; western, southeastern and south-central Washington, including Bellingham, Bremerton, Longview, Aberdeen, Wenatchee/Moses Lake, Mount Vernon, Tri-Cities, Walla Walla and Yakima, and northern Wyoming, including Sheridan and Lovell. In addition to the residential and commercial sales, the utilities transport natural gas for commercial and industrial customers who purchase their own supply of natural gas.

The Company’s purchased natural gas is supplied by a portfolio of contracts specifying market-based pricing and is transported under transportation agreements with WBI Energy Transmission, Inc. (WBI Energy Transmission), Northern Border Pipeline Company, Northwest Pipeline GP, Northern Natural Gas, Gas Transmission Northwest LLC, Northwestern Energy, Viking Gas Transmission Company, Westcoast Energy Inc., Ruby Pipeline LLC, Foothills Pip! e Lines L! td. and NOVA Gas Transmission Ltd. The natural gas distribution operations have contracts for storage services to provide gas supply during the winter heating season and to meet day demand with various storage providers, including WBI Energy Transmission, Questar Pipeline Company, Northwest Pipeline GP and Northern Natural Gas.

Pipeline and Midstream

WBI Energy owns and operates both regulated and nonregulated businesses. The regulated business of this segment, WBI Energy Transmission, owns and operates approximately 4,000 miles of transmission, gathering and storage lines in Montana, North Dakota, South Dakota and Wyoming. Approximately three underground storage fields in Montana and Wyoming provide storage services to local distribution companies, producers, natural gas marketers and others, and serve to provide system deliverability. Its system is located near approximately five natural gas producing basins, making natural gas supplies available to its transportation and storage customers. The system has over 10 interconnecting points with other pipeline facilities allowing for the receipt and/or delivery of natural gas to and from other regions of the country and from Canada. The nonregulated business of this segment owns and operates gathering facilities in Montana and Wyoming. It also owns an interest in the Pronghorn assets located in western North Dakota, which includes a natural gas processing plant, oil and gas gathering pipelines, an oil storage terminal and an oil pipeline. In total, facilities include approximately 800 miles of operated field gathering lines, some of which interconnect with WBI Energy’s regulated pipeline system. The nonregulated business provides natural gas and oil gathering services, natural gas processing and a range of other energy-related services, including cathodic protection, water hauling, contract compression operations, measurement services, and energy manageable product sales and installation services to end users. Its pipeline and mid! stream bu! siness is transacted in the northern Great Plains and Rocky Mountain regions of the United States. WBI Energy Transmission’s underground natural gas storage facilities have a storage capacity of approximately 353 Billion cubic feet (Bcf), including over 190 Bcf of working gas capacity, approximately 90 Bcf of cushion gas and approximately 80 Bcf of native gas.

Construction Materials and Contracting

Knife River operates construction materials and contracting businesses in Alaska, California, Hawaii, Idaho, Iowa, Minnesota, Montana, North Dakota, Oregon, Texas, Washington and Wyoming. These operations mine, process and sell construction aggregates (crushed stone, sand and gravel); produce and sell asphalt mix and supply ready-mixed concrete for use in types of construction, including roads, freeways and bridges, as well as homes, schools, shopping centers, office buildings and industrial parks. Its other products include the sale of cement, liquid asphalt for commercial and roadway applications, finished concrete products and other building materials and related contracting services.

Construction Services

MDU Construction Services provides utility construction services specializing in constructing and maintaining electric and communication lines, gas pipelines, fire suppression systems, and external lighting and traffic signalization. Construction Services segment also provides utility excavation and inside electrical and mechanical services, and manufactures and distributes transmission line construction equipment and other supplies. These services are provided to utilities and manufacturing, commercial, industrial, institutional and government customers. MDU Construction Services operates a fleet of owned and leased trucks and trailers, support vehicles and specialty construction equipment, such as backhoes, excavators, trenchers, generators, boring machines and cranes. In addition, MDU Construction Services owns or leases facilities in approximately 2! 0 states.! This space is used for offices, equipment yards, warehousing, storage and vehicle shops.

Refining

WBI Energy, Inc. (WBI Energy) in conjunction with Calumet Specialty Products Partners, L.P. (Calumet), formed Dakota Prairie Refining, LLC (Dakota Prairie Refining), to develop, build and operate Dakota Prairie Refinery. The refinery processes Bakken crude oil into diesel, naphtha, Atmospheric tower bottoms (ATBs) and other by-products. Bakken crude oil is supplied to the refinery via a pipeline interconnect with the Belle Fourche Pipeline and a portion is trucked to the refinery from wells near the refinery. The refinery sells diesel fuel at the refinery rack to diesel wholesalers. Naphtha is railed to Canada and sold to third parties primarily for use as a diluent for tar sands production. ATBs are railed and sold to other facilities for further processing.

Advisors’ Opinion:

  • [By Stephan Byrd]

    Royal London Asset Management Ltd. bought a new position in MDU Resources Group Inc (NYSE:MDU) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 76,679 shares of the utilities provider’s stock, valued at approximately $2,199,000.

  • [By Logan Wallace]

    Forsta AP Fonden trimmed its holdings in MDU Resources Group Inc (NYSE:MDU) by 13.7% in the second quarter, according to its most recent disclosure with the SEC. The fund owned 64,700 shares of the utilities provider’s stock after selling 10,300 shares during the period. Forsta AP Fonden’s holdings in MDU Resources Group were worth $1,856,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Here are some of the news stories that may have effected Accern’s rankings:

    Get MDU Resources Group alerts:

    MDU Resources Group, Inc. (MDU): Stock Trending Alert (thenewsbloom.org) These Stocks’s might change the Kismet of Investors: Five9, Inc. (NASDAQ:FIVN), MDU Resources Group, Inc. (NYSE … (journalfinance.net) Is this stock Watchful?: MDU Resources Group, Inc. (MDU), Dover Downs Gaming & Entertainment, Inc. (DDE) (newsregistrar.com) MDU Resources Group, Inc. (MDU) crosses above SMA-50 with 0.40% (nasdaqplace.com)

    NYSE MDU opened at $28.48 on Tuesday. The stock has a market cap of $5.59 billion, a PE ratio of 22.10, a price-to-earnings-growth ratio of 3.17 and a beta of 0.64. The company has a current ratio of 1.39, a quick ratio of 1.05 and a debt-to-equity ratio of 0.71. MDU Resources Group has a one year low of $24.29 and a one year high of $29.62.

  • [By Shane Hupp]

    MDU Resources Group (NYSE: MDU) and Zenyatta Ventures (OTCMKTS:ZENYF) are both utilities companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.

Top 10 Casino Stocks To Own Right Now: PriceSmart, Inc.(PSMT)

PriceSmart, Inc. (PriceSmart), incorporated on August 17, 1994, business consists primarily of international membership shopping warehouse clubs similar to warehouse clubs in the United States. The Company owns and operates United States-style membership shopping warehouse clubs through wholly owned subsidiaries operating in Latin America and the Caribbean using the trade name PriceSmart. The Companys operating segments are the United States, Latin America and the Caribbean. The warehouse clubs sell basic high quality consumer goods at low prices to individuals and businesses. The Company ships its United States and other internationally sourced merchandise directly to its warehouse clubs or to the Company’s consolidation points (distribution centers).

The no-frills warehouse club-type buildings range in size from 48,000 to 1,00,000 square feet and are located primarily in urban areas. As of December 1, 2014, the Company had approximately 1.2 million member accounts and 2.3 million card holders. The Company had 36 consolidated warehouse clubs in operation in 12 countries and 1 U.S. territory (6 each in Costa Rica and Colombia; 4 each in Panama and Trinidad; 3 each in Guatemala, Honduras and in the Dominican Republic; 2 in El Salvador; and 1 each in Aruba, Barbados, Jamaica, Nicaragua, and the United States Virgin Islands), of which the Company owns 100% of the corresponding legal entities.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Pricesmart Inc (NASDAQ:PSMT)Q22019 Earnings CallApril 10, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Garrett Baldwin]

    Just Revealed: The Secret to Potentially Growing Incredibly Wealthy Buying Straight-Up Stocks

    Bank of America Corp. (NYSE: BAC) announced plans to raise its minimum wage to $20. The bank plans to hike its minimum wage from $17 on May 1 and do so in two increments over the next two years. The decision comes a year ahead of a critical presidential election that will see a wide debate over minimum wage, universal basic income, and living wages. Keep a close eye on Boeing Co. (NYSE: BA). The firm will announce the number of planes it plans to deliver during the first quarter on Tuesday. The number is critical to analysts who have watched the company fail to deliver any 737 Max planes over the last two weeks. The firm halted deliveries of the aircraft after two crashes involving the same model occurred in the last six months. Look for earnings reports from Shaw Communications Inc.(NYSE: SJR), PriceSmart Inc. (NASDAQ: PSMT), WD-40 Co.(NASDAQ: WDFC).
    This Is How You Can Grow Incredibly Rich Buying Straight-Up Stocks

    Right now, even with all the market uncertainty, there’s truly a ridiculous amount of money to be made from stocks if you follow this secret.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on PriceSmart (PSMT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on PriceSmart (PSMT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Casino Stocks To Own Right Now: Merrimack Pharmaceuticals, Inc.(MACK)

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. Its therapeutic oncology candidates in clinical development include MM-398, a nanotherapeutic encapsulation of the chemotherapy drug irinotecan, which is has completed Phase III clinical trials for the treatment of patients with metastatic pancreatic cancer whose cancer had progressed on treatment with the chemotherapy drug gemcitabine; in a Phase I clinical trial as a monotherapy in patients with glioma and in combination with cyclophosphamide in patients with pediatric solid tumors; and in a Phase 1 translational clinical trial designed to identify predictive biomarkers associated with MM-398. The companys therapeutic oncology candidates also include MM-302 that is in Phase II clinical trial for the treatment of patients with ErbB2 (HER2)-positive, locally advanced or metastatic breast cancer; MM-121, which is in Phase II clinical trial for the treatment of patients with heregulin positive, advanced non-small cell lung cancer, as well as ovarian, breast, and non-small cell lung cancers; and MM-111 that is in a Phase II clinical trial for the treatment of patients with advanced gastric, esophageal, and gastroesophageal junction cancers. In addition, its therapeutic oncology candidates consist of MM-151 and MM-141, which are in Phase I clinical trials for the treatment of patients with solid tumors. The company has collaboration and license agreements with Baxter International Inc., Baxter Healthcare Corporation, Baxter Healthcare SA, Actavis, Sanofi, PharmaEngine, Inc., Dyax Corp., Adimab LLC, and University of California. Merrimack Pharmaceuticals, Inc. was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Advisors’ Opinion:

  • [By Shane Hupp]

    Merrimack Pharmaceuticals Inc (NASDAQ:MACK) shares reached a new 52-week low on Thursday . The stock traded as low as $4.56 and last traded at $4.71, with a volume of 33598 shares. The stock had previously closed at $4.74.

  • [By Max Byerly]

    Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of Merrimack Pharmaceuticals Inc (NASDAQ:MACK) by 22.0% in the second quarter, HoldingsChannel.com reports. The fund owned 174,774 shares of the biopharmaceutical company’s stock after acquiring an additional 31,509 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in Merrimack Pharmaceuticals were worth $858,000 as of its most recent filing with the SEC.

Top 10 Casino Stocks To Own Right Now: THERMOGENESIS Corp.(KOOL)

ThermoGenesis Corp. designs, develops, and sells medical products that enable the practice of regenerative medicine worldwide. It offers automated and semi-automated devices, and single-use processing disposables that enable the collection, processing, and cryopreservation of stem cells and other cellular tissues used in the practice of regenerative medicine. Regenerative medicine is a field that uses cell-based therapies to repair or restore lost or damaged tissue and cell function. The company?s products include the AXP System, a medical device that isolates and retrieves stem cells from umbilical cord blood; the BioArchive System, a robotic cryogenic medical device used by cord blood banks for the cryopreservation and archiving of cord blood stem cell units for transplant; the MarrowXpress or MXP System that isolates and concentrates stem cells from bone marrow; Res-Q 60 BMC, a point-of-care bone marrow stem cell processing system; and Res-Q 60 PRP, which is used for t he preparation of autologous platelet rich plasma from a sample of blood at the point of care. It also offers ThermoLine product line, which includes ultra-rapid plasma ThermoLine Freezer and ultra-rapid plasma ThermoLine Thawer; and CryoSeal System, an automated system, which is used to prepare an autologous hemostatic surgical sealant. ThermoGenesis Corp. was founded in 1986 and is based in Rancho Cordova, California.

Advisors’ Opinion:

  • [By Ethan Ryder]

    Misonix (NASDAQ:MSON) and Cesca Therapeutics (NASDAQ:KOOL) are both small-cap computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, analyst recommendations, valuation, risk and profitability.

  • [By Shane Hupp]

    Cesca Therapeutics (NASDAQ:KOOL) and Misonix (NASDAQ:MSON) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends and risk.

  • [By Max Byerly]

    Media headlines about Cesca Therapeutics (NASDAQ:KOOL) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cesca Therapeutics earned a daily sentiment score of 0.15 on Accern’s scale. Accern also assigned news coverage about the biotechnology company an impact score of 46.0307775258496 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Top 10 Casino Stocks To Own Right Now: Avangrid, Inc.(AGR)

Avangrid, Inc. operates as a diversified energy and utility company in the United States. It provides electricity transmission and distribution, and natural gas distribution services. The company operates eight electric and natural gas utilities serving 3.1 million customers in Connecticut, Maine, Massachusetts, and New York; and 120 billion cubic feet of owned or contracted natural gas storage and hub service facilities in Alabama, Mississippi, New Mexico, and Texas. It also develops, constructs, and operates renewable energy generation facilities using wind, solar, and thermal power. The company, formerly known as Iberdrola USA, Inc., was founded in 1852 and is based in New Gloucester, Maine. Avangrid, Inc. is a subsidiary of Iberdrola, S.A.

Advisors’ Opinion:

  • [By Max Byerly]

    WARNING: “Avangrid (AGR) Trading Down 5.2% Following Weak Earnings” was originally reported by Ticker Report and is the property of of Ticker Report. If you are viewing this piece of content on another domain, it was copied illegally and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be accessed at www.tickerreport.com/banking-finance/4167294/avangrid-agr-trading-down-5-2-following-weak-earnings.html.

  • [By Stephan Byrd]

    Avangrid (NYSE:AGR) updated its FY 2019 earnings guidance on Tuesday. The company provided EPS guidance of $2.25-2.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.42.

  • [By Shane Hupp]

    Voya Investment Management LLC cut its position in Avangrid Inc (NYSE:AGR) by 11.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 25,259 shares of the utilities provider’s stock after selling 3,184 shares during the quarter. Voya Investment Management LLC’s holdings in Avangrid were worth $1,337,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Pampa Energia (NYSE:PAM) and Avangrid (NYSE:AGR) are both utilities companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

Top 10 Casino Stocks To Own Right Now: OncoSec Medical Incorporated(ONCS)

We are a biotechnology company focused on designing, developing and commercializing innovative gene therapies, therapeutics and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer. We seek to overcome the problem of tumor-induced immune subversion via intratumoral immunotherapy.

Our Business and Mission

Our mission is to pursue the advancement of immune system-stimulating treatments through the advancement of our proprietary immunotherapy platform which is designed to overcome tumor immune tolerance. Our proprietary intratumoral electroporation-based therapy is a platform which includes immune modulating therapeutic product candidates intended to treat a wide range of solid tumor types, combined with our ImmunoPulse庐 delivery technology.   Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    Here are last week’s top-performing penny stocks:

    Penny Stock Current Share Price Last Week’s Gain
    AVEO Pharmaceuticals Inc. (NASDAQ: AVEO) $1.58 176%
    Pulmatrix Inc. (NASDAQ: PULM) $2.02 68.33%
    Social Reality Inc. (NASDAQ: SRAX) $3.67 66.82%
    EDAP Tms SA (NASDAQ: EDAP) $1.10 48.92%
    Cel-Sci Corp. (NYSE: CVM) $4.35 41.16%
    Sharing Economy International Inc. (OTCMKTS: SEII) $0.17 38.66%
    Riot Blockchain Inc. (NASDAQ: RIOT) $4.34 36.07%
    Technical Communications Corp. (NASDAQ: TCCO) $4.15 35.90%
    OnCoSec Medical Inc. (NASDAQ: ONCS) $0.67 35.78%
    Lightbridge Corp. (NASDAQ: LTBR) $0.74 35.49%

    As you can see, last week’s penny stocks already beat April’s average return by a large margin.

  • [By Max Byerly]

    OncoSec Medical Inc (NASDAQ:ONCS) traded up 5.9% on Wednesday . The stock traded as high as $1.45 and last traded at $1.43. 506,563 shares changed hands during mid-day trading, a decline of 31% from the average session volume of 730,660 shares. The stock had previously closed at $1.35.

  • [By Stephan Byrd]

    HC Wainwright set a $4.00 price target on OncoSec Medical (NASDAQ:ONCS) in a research report released on Tuesday. The firm currently has a buy rating on the biotechnology company’s stock.

Top 10 Casino Stocks To Own Right Now: Jabil Circuit Inc.(JBL)

Jabil Circuit, Inc., together with its subsidiaries, provides electronic manufacturing services and solutions worldwide. The company offers electronics and mechanical design, production, product management, and after-market services to companies in the aerospace, automotive, computing, consumer, defense, industrial, instrumentation, medical, networking, peripherals, solar, storage, and telecommunications industries. Its services comprise integrated design and engineering; component selection, sourcing, and procurement; automated assembly; design and implementation of product testing; parallel global production; enclosure services; and systems assembly, direct-order fulfillment, and configure-to-order services. The company also provides set-top boxes, mobility products, and display products, as well as peripheral products, such as printers and point of sale terminals; and aftermarket services consisting of warranty and repair services. Jabil Circuit, Inc. was founded in 196 6 and is headquartered in St. Petersburg, Florida.

Advisors’ Opinion:

  • [By ]

    As a great illustration of this, the FBALX portfolio currently holds long-term U.S. Treasury bonds in its top holdings alongside mega-cap insurer UnitedHealthGroup and mid-cap electronic component company Jabil (JBL). That's quite a wide swath of the market to cover!

  • [By Motley Fool Transcribers]

    Jabil Circuit Inc (NYSE:JBL)Q22019 Earnings Conference CallMarch 14, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Best Clean Energy Stocks To Watch For 2019

Clean energy stocks in 2018 are on the cusp of massive growth, as the sector is projected to expand by 500% in the United States alone…

The Energy Information Agency is projecting renewable energy production to grow 500% by 2040.

The World’s First “Universal Fuel”: Physicists have known about an unlimited source of free fuel for over 100 years. See why tech companies are investing millions in this fuel (and how to join them). Click here…

And that means right now is the time to invest in clean energy stocks before they begin to soar.

To help Money Morning readers profit from the massive industry growth ahead, we’re giving our readers one of the best clean energy stocks to buy right now. More on that pick in just a bit, but we want to first show you why the renewable energy sector is set to soar…

How Renewables Will Power Clean Energy Stocks in 2018

There are three major catalysts propelling alternative energy sources to explosive growth potential. And as the sector grows, so will renewable energy stocks…

Best Clean Energy Stocks To Watch For 2019: Bloomin' Brands, Inc.(BLMN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    BidaskClub downgraded shares of Bloomin’ Brands (NASDAQ:BLMN) from a hold rating to a sell rating in a research note issued to investors on Tuesday.

  • [By Joseph Griffin]

    Bloomin’ Brands (NASDAQ: BLMN) and Brinker International (NYSE:EAT) are both small-cap retail/wholesale companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

  • [By Joseph Griffin]

    Equities research analysts expect Bloomin’ Brands Inc (NASDAQ:BLMN) to report earnings per share of $0.08 for the current fiscal quarter, Zacks Investment Research reports. Five analysts have made estimates for Bloomin’ Brands’ earnings. The highest EPS estimate is $0.12 and the lowest is $0.05. Bloomin’ Brands reported earnings of $0.12 per share during the same quarter last year, which indicates a negative year over year growth rate of 33.3%. The business is scheduled to issue its next earnings report on Friday, November 2nd.

  • [By Sean Williams]

    The casual-dining restaurant stock I’d most suggest avoiding in this industry is Bloomin’ Brands (NASDAQ:BLMN), the parent of Outback Steakhouse, Carrabba’s Italian Grill, Bonefish Grill, and Fleming’s Steakhouse.

Best Clean Energy Stocks To Watch For 2019: Valspar Corporation (VAL)

Advisors’ Opinion:

  • [By Max Byerly]

    Valorbit (CURRENCY:VAL) traded 0% higher against the dollar during the 1 day period ending at 11:00 AM Eastern on June 9th. One Valorbit coin can currently be bought for approximately $0.0001 or 0.00000001 BTC on exchanges. Valorbit has a market cap of $537,598.00 and $0.00 worth of Valorbit was traded on exchanges in the last 24 hours. In the last seven days, Valorbit has traded up 5.8% against the dollar.

  • [By Shane Hupp]

    Shares of ValiRx Plc (LON:VAL) rose 5.6% during mid-day trading on Thursday . The company traded as high as GBX 1.90 ($0.02) and last traded at GBX 1.90 ($0.02). Approximately 587,748 shares were traded during trading, a decline of 85% from the average daily volume of 3,820,000 shares. The stock had previously closed at GBX 1.80 ($0.02).

  • [By Stephan Byrd]

    Valorbit (CURRENCY:VAL) traded up 0% against the U.S. dollar during the 1 day period ending at 0:00 AM E.T. on June 18th. One Valorbit coin can now be bought for approximately $0.0001 or 0.00000001 BTC on popular exchanges. Valorbit has a total market capitalization of $537,598.00 and $0.00 worth of Valorbit was traded on exchanges in the last day. During the last week, Valorbit has traded 5.8% higher against the U.S. dollar.

Best Clean Energy Stocks To Watch For 2019: Merrimack Pharmaceuticals, Inc.(MACK)

Advisors’ Opinion:

  • [By Max Byerly]

    Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:

    Get Merrimack Pharmaceuticals alerts:

    Biotech Stock Roundup: PBYI Soars, MACK Crashes, GILD's Biktarvy Gets EC Nod (finance.yahoo.com) Merrimack Fails Phase 2 Pancreatic Cancer Study, But Opportunity Remains (seekingalpha.com) Merrimack Pharmaceuticals’ (MACK) “Hold” Rating Reaffirmed at Robert W. Baird (americanbankingnews.com) Merrimack Crashes as Phase II Pancreatic Cancer Study Fails (zacks.com) MM-141 (benzinga.com)

    Several equities analysts have commented on MACK shares. Zacks Investment Research raised Merrimack Pharmaceuticals from a “hold” rating to a “buy” rating and set a $9.50 price objective on the stock in a research report on Wednesday, April 25th. JPMorgan Chase & Co. downgraded Merrimack Pharmaceuticals from a “neutral” rating to an “underweight” rating in a research report on Monday. Robert W. Baird cut their price objective on Merrimack Pharmaceuticals from $12.00 to $7.00 and set a “neutral” rating on the stock in a research report on Tuesday. Finally, ValuEngine raised Merrimack Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Tuesday.

  • [By Chris Lange]

    Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) shares were absolutely crushed on Monday after the firm gave an update from its midstage pancreatic cancer study. Specifically, the top-line results come from the CARRIE study, a randomized Phase 2 trial evaluating the addition of MM-141 (istiratumab) to standard-of-care treatment in patients with previously untreated metastatic pancreatic cancer.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million.
    Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter.
    Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss.
    Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering.
    Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday.
    Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday.
    Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results.
    Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday.
    Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report.
    GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading.
    Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market

Best Clean Energy Stocks To Watch For 2019: Timken Company (TKR)

Advisors’ Opinion:

  • [By Max Byerly]

    ValuEngine downgraded shares of Timken (NYSE:TKR) from a sell rating to a strong sell rating in a research report sent to investors on Monday.

    A number of other research firms have also recently commented on TKR. Bank of America increased their target price on Timken from $50.00 to $51.00 and gave the company an underperform rating in a research note on Tuesday, May 22nd. Stifel Nicolaus upgraded shares of Timken from a hold rating to a buy rating and upped their price target for the company from $52.00 to $60.00 in a research report on Monday, May 28th. Zacks Investment Research lowered shares of Timken from a buy rating to a hold rating in a research report on Wednesday, March 21st. Vertical Research upgraded shares of Timken from a hold rating to a buy rating in a research report on Friday, May 4th. Finally, CL King began coverage on shares of Timken in a research report on Thursday, June 28th. They set a neutral rating for the company. Three equities research analysts have rated the stock with a sell rating, one has issued a hold rating and seven have assigned a buy rating to the stock. Timken currently has a consensus rating of Hold and an average target price of $52.83.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Timken (TKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    CryptoInsight (CURRENCY:TKR) traded flat against the dollar during the 24 hour period ending at 21:00 PM Eastern on September 11th. One CryptoInsight token can now be purchased for about $0.0040 or 0.00000063 BTC on major exchanges including HitBTC and IDEX. Over the last week, CryptoInsight has traded down 15.8% against the dollar. CryptoInsight has a market cap of $49,784.00 and $0.00 worth of CryptoInsight was traded on exchanges in the last 24 hours.

  • [By Logan Wallace]

    Bank of Montreal Can acquired a new position in shares of Timken Co (NYSE:TKR) during the second quarter, HoldingsChannel reports. The firm acquired 2,822 shares of the industrial products company’s stock, valued at approximately $123,000.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Timken (TKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Medical Stocks To Watch Right Now

Northern Trust Corp increased its holdings in Medical Properties Trust, Inc. (NYSE:MPW) by 3.3% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 8,342,841 shares of the real estate investment trust’s stock after purchasing an additional 265,411 shares during the quarter. Northern Trust Corp’s holdings in Medical Properties Trust were worth $108,457,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. First Dallas Securities Inc. purchased a new stake in shares of Medical Properties Trust in the 4th quarter worth about $106,000. Signaturefd LLC purchased a new stake in shares of Medical Properties Trust in the 1st quarter worth about $102,000. Smith Asset Management Group LP boosted its position in shares of Medical Properties Trust by 93.4% in the 1st quarter. Smith Asset Management Group LP now owns 8,351 shares of the real estate investment trust’s stock worth $108,000 after buying an additional 4,032 shares in the last quarter. Assetmark Inc. boosted its position in shares of Medical Properties Trust by 485.0% in the 4th quarter. Assetmark Inc. now owns 9,676 shares of the real estate investment trust’s stock worth $133,000 after buying an additional 8,022 shares in the last quarter. Finally, Campbell & CO Investment Adviser LLC purchased a new stake in shares of Medical Properties Trust in the 1st quarter worth about $149,000. Institutional investors and hedge funds own 78.29% of the company’s stock.

Top Medical Stocks To Watch Right Now: Shaw Communications Inc.(SJR)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shaw Communications (TSE:SJR.B) (NYSE:SJR) had its price objective boosted by analysts at National Bank Financial from C$28.00 to C$29.00 in a report issued on Wednesday. The firm currently has a “sector perform” rating on the stock. National Bank Financial’s price target would suggest a potential upside of 4.50% from the company’s current price.

  • [By Shane Hupp]

    Montrusco Bolton Investments Inc. trimmed its position in shares of Shaw Communications Inc Class B (NYSE:SJR) (TSE:SJR.B) by 10.0% during the third quarter, HoldingsChannel reports. The firm owned 89,067 shares of the company’s stock after selling 9,913 shares during the period. Montrusco Bolton Investments Inc.’s holdings in Shaw Communications Inc Class B were worth $1,734,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Shaw Communications Inc (TSE:SJR.B) (NYSE:SJR) announced a monthly dividend on Monday, May 14th, TickerTech reports. Stockholders of record on Wednesday, May 30th will be paid a dividend of 0.0988 per share on Wednesday, May 30th. This represents a $1.19 dividend on an annualized basis and a dividend yield of 4.57%. The ex-dividend date of this dividend is Monday, May 14th.

  • [By Garrett Baldwin]

    The price of Bitcoin surged more than 17% to top $8,000 in a rapid move that surprised many investors this morning. The sudden rally appears to be the result of a short squeeze, according to CNBC contributor Brian Kelly. This means that investors who had been betting on a decline in the price of the world’s largest cryptocurrency had been forced to jump back and buy the currency again. A lot of people have been betting on a decline in the price of Bitcoin heading toward the April 17 tax deadline. The expectation is that many people will need to sell their Bitcoin in order to raise cash to meet tax obligations. Here’s our latest daily insight on why the Bitcoin bear market may end very soon.
    Markets gains have been capped by concerns about the latest news out of the Federal Reserve. On Wednesday, minutes from the Fed’s most recent meeting indicated that policy makers are prepared to raise interest rates several more times in the coming months in order to stave off concerns about inflation.
    Four Stocks to Watch Today: BLK, FB, DAL
    Shares of BlackRock Inc. (NYSE: BLK) are on the move after the company reported earnings before the bell. The firm reported earnings per share (EPS) of $6.70. Analysts projected the firm would report EPS of $6.45 on top of $3.28 billion in revenue. The firm topped revenue expectations. The firm noted that an increase in its consulting fees and the recent tax reform bill helped bolster its profitability by 27%.
    The stock of Facebook Inc. (Nasdaq: FB) has climbed more than 6% since Tuesday. Investors cheered the testimony of CEO Mark Zuckerberg, who appeared before Congress for two days to discuss his company’s privacy policies. The CEO and his firm have been under intense scrutiny since news broke that 87 million user accounts had been accessed without permission by consulting firm Cambridge Analytica during the 2016 election season. The firm had ties to President Trump’s campaign.
    Delta Air Lines Inc. (NYSE: DAL) reported ea

  • [By Joseph Griffin]

    ITV PLC/ADR (OTCMKTS: ITVPY) and Shaw Communications Inc Class B (NYSE:SJR) are both mid-cap consumer discretionary companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, analyst recommendations, profitability, institutional ownership and valuation.

  • [By Anders Bylund]

    Let me introduce you to Canadian cable company Shaw Communications (NYSE:SJR), retail-focused REIT Realty Income (NYSE:O), and equity investment firm Main Street Capital (NYSE:MAIN). All of these companies send out monthly dividend payments.

Top Medical Stocks To Watch Right Now: First Horizon National Corporation(FHN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Cadence Capital Management LLC boosted its holdings in First Horizon National Corp (NYSE:FHN) by 173.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,515 shares of the financial services provider’s stock after buying an additional 19,357 shares during the quarter. Cadence Capital Management LLC’s holdings in First Horizon National were worth $544,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Zurcher Kantonalbank Zurich Cantonalbank increased its position in First Horizon National Co. (NYSE:FHN) by 26.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,122 shares of the financial services provider’s stock after buying an additional 3,761 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in First Horizon National were worth $341,000 at the end of the most recent quarter.

  • [By Motley Fool Staff]

    First Horizon National (NYSE:FHN) Q2 2018 Earnings Conference CallJul. 17, 2018 9:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By ]

    In this environment, investors should be looking to add the banks to their portfolios. He likes Goldman Sachs (GS) and First Horizon National (FHN) , which appeared on “Mad Money” last week. He would avoid any high-yielding stock however, as they are getting increased competition from risk-free Treasuries.

  • [By Logan Wallace]

    First Horizon National (NYSE:FHN) will be posting its quarterly earnings results before the market opens on Thursday, July 12th.

    First Horizon National (NYSE:FHN) last posted its earnings results on Friday, April 13th. The financial services provider reported $0.34 EPS for the quarter, topping the Zacks’ consensus estimate of $0.30 by $0.04. First Horizon National had a return on equity of 9.37% and a net margin of 12.30%. The business had revenue of $437.20 million for the quarter, compared to analysts’ expectations of $438.60 million. During the same quarter in the previous year, the firm earned $0.23 earnings per share. The business’s revenue was up 42.6% compared to the same quarter last year. On average, analysts expect First Horizon National to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Top Medical Stocks To Watch Right Now: Marlin Business Services Corp.(MRLN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    First Bank (NASDAQ: FRBA) and Marlin Business Services (NASDAQ:MRLN) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.

  • [By Motley Fool Transcribers]

    Marlin Business Services Corp  (NASDAQ:MRLN)Q4 2018 Earnings Conference CallFeb. 01, 2019, 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top Medical Stocks To Watch Right Now: Merrimack Pharmaceuticals, Inc.(MACK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million.
    Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter.
    Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss.
    Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering.
    Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday.
    Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday.
    Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results.
    Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday.
    Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report.
    GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading.
    Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market

  • [By Max Byerly]

    Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:

    Get Merrimack Pharmaceuticals alerts:

    Biotech Stock Roundup: PBYI Soars, MACK Crashes, GILD's Biktarvy Gets EC Nod (finance.yahoo.com) Merrimack Fails Phase 2 Pancreatic Cancer Study, But Opportunity Remains (seekingalpha.com) Merrimack Pharmaceuticals’ (MACK) “Hold” Rating Reaffirmed at Robert W. Baird (americanbankingnews.com) Merrimack Crashes as Phase II Pancreatic Cancer Study Fails (zacks.com) MM-141 (benzinga.com)

    Several equities analysts have commented on MACK shares. Zacks Investment Research raised Merrimack Pharmaceuticals from a “hold” rating to a “buy” rating and set a $9.50 price objective on the stock in a research report on Wednesday, April 25th. JPMorgan Chase & Co. downgraded Merrimack Pharmaceuticals from a “neutral” rating to an “underweight” rating in a research report on Monday. Robert W. Baird cut their price objective on Merrimack Pharmaceuticals from $12.00 to $7.00 and set a “neutral” rating on the stock in a research report on Tuesday. Finally, ValuEngine raised Merrimack Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Tuesday.

  • [By Max Byerly]

    Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of Merrimack Pharmaceuticals Inc (NASDAQ:MACK) by 22.0% in the second quarter, HoldingsChannel.com reports. The fund owned 174,774 shares of the biopharmaceutical company’s stock after acquiring an additional 31,509 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in Merrimack Pharmaceuticals were worth $858,000 as of its most recent filing with the SEC.

Top Medical Stocks To Watch Right Now: Neuberger Berman MLP Income Fund Inc.(NML)

Advisors’ Opinion:

  • [By Ethan Ryder]

    New Millennium Iron Corp (TSE:NML)’s share price reached a new 52-week low during trading on Monday . The stock traded as low as C$0.07 and last traded at C$0.07, with a volume of 21500 shares traded. The stock had previously closed at C$0.07.

  • [By Logan Wallace]

    Neuberger Berman MLP Income Fund Inc (NYSEAMERICAN:NML) declared a monthly dividend on Monday, October 1st, Wall Street Journal reports. Investors of record on Monday, December 17th will be given a dividend of 0.055 per share by the investment management company on Monday, December 31st. This represents a $0.66 dividend on an annualized basis and a dividend yield of 7.42%. The ex-dividend date is Friday, December 14th.

Top Medical Stocks To Watch Right Now: VIVUS, Inc.(VVUS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on VIVUS (VVUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on VIVUS (VVUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning News Team]

    Seadrill’s rally demonstrates how profitable penny stocks can be for savvy investors. With Seadrill’s gains already on the books, we’ll look at a stock that’s on track to generate tremendous returns – a small cap that just completed a groundbreaking acquisition with huge profit potential…

    Penny Stock Current Share Price Law Week’s Gain
    Seadrill Ltd. (NYSE: SDRL) $0.58 98.74%
    Vivis Inc. (Nasdaq: VVUS) $0.83 59.97%
    MEI Pharma Inc. (Nasdaq: MEIP) $3.45 43.40%
    Transenterix Inc. (NYSE: TRXC) $3.15 35.72%
    Akers Biosciences Inc. (Nasdaq: AKER) $0.65 34.38%
    Galectin Therapeutics Inc. (Nasdaq: GALT) $4.54 32.58%
    Phoenix New Media Ltd. (NYSE ADR: FENG) $5.65 32.22%
    Heat Biologics Inc. (Nasdaq: HTBX) $1.73 31.37%
    Bright Scholar Education Ltd. (NYSE ADR: BEDU) $18.51 29.03%
    21 Vianet Group Inc. (Nasdaq: VNET) $7.36 28.72%

    These gains are incredibly exciting. However, not all penny stocks are equally strong investments.

  • [By Logan Wallace]

    Media stories about VIVUS (NASDAQ:VVUS) have been trending somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. VIVUS earned a news impact score of 0.13 on Accern’s scale. Accern also gave press coverage about the biopharmaceutical company an impact score of 47.022479468622 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Money Morning Staff Reports]

    But Blink and our other penny stocks to watch are unlikely to continue to lock in such spectacular gains in June. After looking at our 10 top penny stocks to watch this month, we’ll show you a small-cap stock with great profit potential in its future…

    Penny Stock Current Share Price Law Month’s Gain
     Blink Charging Co. (Nasdaq: BLNK) $7.07 439.85%
    Senes Tech Inc. (Nasdaq: SNES) $1.27 175.40%
    Vivis Inc. (Nasdaq: VVUS) $0.77 150.41%
    Adomani Inc. (Nasdaq: ADOM) $1.49 137.68%
    NF Energy Saving Co. (Nasdaq: NFEC) $2.34 134.88%
    Vaalco Energy Inc. (NYSE: EGY) $2.15 109.06%
    Heat Biologics Inc. (Nasdaq: HTBX) $2.35 99.12%
    ArQule Inc. (Nasdaq: ARQL) $4.88 90.74%
    LiqTech International Inc. (NYSE: LIQT) $0.66 85.60%
    Transenterix Inc. (NYSE: TRXC) $3.46 77.84%

    While last month’s gains are tremendous, they also illustrate the inherent dangers that come with investing in penny stocks.

Hot Blue Chip Stocks To Watch Right Now

As we know, the broad stock market indices have been resilient all year. And that strength, in large part, can be credited to a small group of stocks.

Among that group, the blue chip Internet stocks have led the way: Facebook, Amazon, Apple, Google and Netflix. Halfway through the year, those five stocks were up more than 40% on average. And those five stocks carry a lot of weight in the performance of the indexes.

And given the valuation of the index, you constantly hear how the market is overvalued or "fairly valued." It’s not true, for the reasons we’ve often discussed, related to historical low interest rates environments. And it’s certainly not true for the energy sector.

Take a look at energy performance year-to-date relative to the rest of the market:

Hot Blue Chip Stocks To Watch Right Now: Rubicon Technology, Inc.(RBCN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Rubicon Technology (NASDAQ:RBCN) was downgraded by investment analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued on Thursday.

Hot Blue Chip Stocks To Watch Right Now: Tahoe Resources, Inc.(TAHO)

Advisors’ Opinion:

  • [By Logan Wallace]

    Tahoe Resources (TSE:THO) (NASDAQ:TAHO) – Equities research analysts at National Bank Financial reduced their FY2018 earnings estimates for shares of Tahoe Resources in a research report issued on Monday, April 9th. National Bank Financial analyst M. Parkin now forecasts that the company will earn $0.29 per share for the year, down from their prior forecast of $0.35. National Bank Financial currently has a “Sector Perform” rating and a $8.00 price objective on the stock.

Hot Blue Chip Stocks To Watch Right Now: Simmons First National Corporation(SFNC)

Advisors’ Opinion:

  • [By Logan Wallace]

    Simmons First National Co. (NASDAQ:SFNC) reached a new 52-week high and low during trading on Friday . The stock traded as low as $31.10 and last traded at $30.80, with a volume of 3453 shares traded. The stock had previously closed at $30.95.

Hot Blue Chip Stocks To Watch Right Now: Carrols Restaurant Group Inc.(TAST)

Advisors’ Opinion:

  • [By Stephan Byrd]

    BidaskClub upgraded shares of Carrols Restaurant Group (NASDAQ:TAST) from a strong sell rating to a sell rating in a report released on Wednesday.

    Several other research analysts also recently commented on the stock. ValuEngine raised shares of Carrols Restaurant Group from a sell rating to a hold rating in a report on Tuesday. Zacks Investment Research downgraded shares of Carrols Restaurant Group from a buy rating to a hold rating in a report on Saturday, May 5th. Dougherty & Co reaffirmed a buy rating on shares of Carrols Restaurant Group in a report on Sunday, March 4th. Finally, Citigroup cut their price objective on shares of Carrols Restaurant Group from $16.00 to $15.00 and set a buy rating for the company in a report on Monday, March 5th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have assigned a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus price target of $14.50.

  • [By Lisa Levin] Gainers
    Integrated Media Technology Limited (NASDAQ: IMTE) rose 30.8 percent to $22.00 in pre-market trading after declining 18.63 percent on Monday.
    Nevsun Resources Ltd. (NYSE: NSU) rose 14.5 percent to $3.40 in pre-market trading after Lundin Mining Corporation and Euro Sun Mining Inc. proposed to acquire Nevsun Resources for around C$1.5 billion.
    Sharing Economy International Inc. (NASDAQ: SEII) rose 15.2 percent to $4.25 in pre-market trading after the company disclosed that it entered into a license agreement with Ecrent Capital Holdings Limited.
    Veeco Instruments Inc. (NASDAQ: VECO) shares rose 14.1 percent to $19.50 in pre-market trading after reporting stronger-than-expected earnings for its first quarter.
    Impinj, Inc. (NASDAQ: PI) rose 13.4 percent to $15.40 in pre-market trading after reporting Q1 results.
    SandRidge Energy, Inc. (NYSE: SD) shares rose 13.2 percent to $16.45 in pre-market trading following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 12.6 percent to $4.55 in pre-market trading after jumping 171.14 percent on Monday.
    Crocs, Inc. (NASDAQ: CROX) shares rose 10 percent to $16.66 in pre-market trading after the company reported better-than-expected earnings for its first quarter and issued strong sales forecast for the second quarter.
    Pareteum Corporation (NASDAQ: TEUM) rose 9.7 percent to $3.05 in pre-market trading after announcing Q1 results.
    Dean Foods Company (NYSE: DF) rose 8 percent to $9.00 in pre-market trading after reporting upbeat Q1 earnings.
    Fiesta Restaurant Group, Inc. (NASDAQ: FRGI) rose 7.3 percent to $23.45 in pre-market trading following Q1 results.
    IAMGOLD Corporation (NYSE: IAG) rose 7.1 percent to $6.09 in pre-market trading after reporting upbeat Q1 earnings.
    TC PipeLines, LP (NYSE: TCP) rose 6.4 percent to $27 in pre-market trading after gaining 2.08 percent on Monday.
    Carrols Restaurant Group, Inc. (NASDAQ: TAST) rose 6.3 percent to $11.75 in pre-market trading fol
  • [By Steve Symington]

    Burger King franchisee Carrols Restaurant Group, Inc. (NASDAQ:TAST) announced strong first-quarter 2018 results on Tuesday morning, showcasing continued momentum in both comparable-restaurant sales and revenue from acquired locations over the past year. Carrols was also able to considerably narrow its losses in this seasonally slow quarter.

  • [By Lisa Levin] Gainers
    ProPhase Labs, Inc. (NASDAQ: PRPH) gained 50.7 percent to $4.34 after the company announced a special $1.00 per share cash dividend.
    Impinj, Inc. (NASDAQ: PI) surged 28.4 percent to $17.44 after reporting Q1 results.
    Cardlytics, Inc. (NASDAQ: CDLX) gained 22 percent to $17.945.
    Care.com, Inc. (NYSE: CRCM) shares rose 19.3 percent to $18.92 following Q1 earnings.
    Sharing Economy International Inc. (NASDAQ: SEII) jumped 19.1 percent to $4.3934 after the company disclosed that it entered into a license agreement with Ecrent Capital Holdings Limited.
    Blink Charging Co. (NASDAQ: BLNK) rose 18.6 percent to $4.79 after jumping 171.14 percent on Monday.
    IntriCon Corporation (NASDAQ: IIN) climbed 17.4 percent to $29.30 after reporting Q1 results.
    Nevsun Resources Ltd. (NYSE: NSU) rose 16.2 percent to $3.45 after Lundin Mining Corporation and Euro Sun Mining Inc. proposed to acquire Nevsun Resources for around C$1.5 billion.
    Tactile Systems Technology, Inc. (NASDAQ: TCMD) gained 15.4 percent to $42.61 following Q1 results.
    eGain Corporation (NASDAQ: EGAN) gained 15.3 percent to $10.55 following Q3 earnings.
    Dean Foods Company (NYSE: DF) rose 13.8 percent to $9.48 after reporting upbeat Q1 earnings.
    Sterling Construction Company, Inc. (NASDAQ: STRL) shares surged 13.1 percent to $13.42 after reporting Q1 results.
    USA Technologies, Inc. (NASDAQ: USAT) climbed 11.9 percent to $10.85 following better-than-expected Q3 earnings.
    scPharmaceuticals Inc. (NASDAQ: SCPH) gained 11.2 percent to $14.45 following Q1 results.
    Fiesta Restaurant Group, Inc. (NASDAQ: FRGI) rose 10.2 percent to $24.08 following Q1 results.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 7.9 percent to $19.60 as the company posted upbeat Q1 results and raised its outlook.
    Carrols Restaurant Group, Inc. (NASDAQ: TAST) rose 7.7 percent to $11.90 following upbeat Q1 results.
    Pareteum Corporation (NASDAQ: TEUM) rose 6.8 perc

Hot Blue Chip Stocks To Watch Right Now: Merrimack Pharmaceuticals, Inc.(MACK)

Advisors’ Opinion:

  • [By Shane Hupp]

    Here are some of the media headlines that may have effected Accern Sentiment Analysis’s rankings:

    Get Merrimack Pharmaceuticals alerts:

    Edited Transcript of MACK earnings conference call or presentation 8-May-18 12:30pm GMT (finance.yahoo.com) Investors Purchase High Volume of Merrimack Pharmaceuticals Call Options (MACK) (americanbankingnews.com) Merrimack (MACK) Reports Wider-Than-Expected Loss in Q1 (finance.yahoo.com) Merrimack Pharmaceuticals (MACK) Announces Quarterly Earnings Results, Misses Expectations By $0.05 EPS (americanbankingnews.com) Merrimack Pharmaceuticals’ (MACK) CEO Richard Peters on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com)

    A number of equities analysts have issued reports on MACK shares. Robert W. Baird reiterated a “hold” rating and issued a $12.00 price objective on shares of Merrimack Pharmaceuticals in a report on Thursday, March 15th. Zacks Investment Research upgraded Merrimack Pharmaceuticals from a “hold” rating to a “buy” rating and set a $9.50 price objective for the company in a report on Wednesday, April 25th.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million.
    Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter.
    Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss.
    Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering.
    Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday.
    Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday.
    Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results.
    Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday.
    Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report.
    GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading.
    Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market

Top Medical Stocks To Buy For 2018

Boston, MA, based Investment company North Tide Capital, Llc buys Impax Laboratories, Allergan PLC, Accuray, sells Community Health Systems, Valeant Pharmaceuticals International, Mylan NV, Perrigo Co PLC, Select Medical Holdings during the 3-months ended 2016-12-31, according to the most recent filings of the investment company, North Tide Capital, Llc. As of 2016-12-31, North Tide Capital, Llc owns 14 stocks with a total value of $483 million. These are the details of the buys and sells.

New Purchases: IPXL, AGN, ARAY, Added Positions: MYGN, KND, Reduced Positions: MYL, SEM, SVU, GILD, LPNT, Sold Out: CYH, VRX, PRGO, AFAM, ADUS,

For the details of NORTH TIDE CAPITAL, LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=NORTH+TIDE+CAPITAL%2C+LLC

These are the top 5 holdings of NORTH TIDE CAPITAL, LLCSelect Medical Holdings Corp (SEM) – 10,000,000 shares, 27.46% of the total portfolio. Shares reduced by 23.66%SUPERVALU Inc (SVU) – 18,469,921 shares, 17.87% of the total portfolio. Shares reduced by 24.61%Gilead Sciences Inc (GILD) – 500,000 shares, 7.42% of the total portfolio. Shares reduced by 37.5%Kindred Healthcare Inc (KND) – 4,250,000 shares, 6.91% of the total portfolio. Shares added by 6.25%Syneron Medical Ltd (ELOS) – 3,500,000 shares, 6.09% of the total portfolio. New Purchase: Impax Laboratories Inc (IPXL)

North Tide Capital, Llc initiated holdings in Impax Laboratories Inc. The purchase prices were between $12.75 and $24.23, with an estimated average price of $17.1. The stock is now traded at around $9.15. The impact to the portfolio due to this purchase was 5.49%. The holdings were 2,000,000 shares as of 2016-12-31.

Top Medical Stocks To Buy For 2018: Biotricity (BTCY)

Advisors’ Opinion:

  • [By Robert J. Smith]

    Biotricity (OTCBB: BTCY) is a comer in the rapidly growing medical device market and is a small cap to take notice of. Driving this lucrative market are; IoT-driven device connectivity, governmental pressure to cut healthcare costs, escalating hospital costs, a need to reduce hospital readmission rates, an aging population, and a high rate of people with chronic disease. The largest factor driving this market is the rapidly growing rate of those afflicted with chronic disease.

  • [By Peter Graham]

    Sandhill.com recently interviewed the chairman, CEO and founder Waqaas Al-Siddiq small cap wearables stock Biotricity (OTCQB: BTCY) about how wearables benefit patients, integrate into healthcare systems and improve treatment compliance as well as how the cloud and the Internet of Things impact the medical wearables space. biotricitys is a medical technology company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. biotricitys R&D focuses on the preventative healthcare market, with a vision of putting health management into the hands of the individual by supporting the self-management of critical and chronic conditions.

  • [By Matthew Briar]

    Ever heard the term ‘mHealth’? Or, maybe you’ve heard it by the full-length (and less hip) characterization mobile health. Regardless of what you call it, it’s the same … it’s the Q&D way to describe the new era of healthcare and medical equipment that operates outside of a hospital or clinic, and doesn’t require any wires to function. It’s the new way of taking care of patients, and more important, it’s a huge market. The mHealth market is projected to grow from $13.6 billion in 2015 to $49.1 billion by 2020, as the premise and technology hits a critical mass.

    It’s an undertow – a paradigm shift – that favors lots of small cap stocks, but perhaps none as much as Biotricity Inc (OTCMKTS:BTCY).

    Biotricity isn’t a household name. It may be soon, however. It’s the developer of two different but related wearable, 24/7 heart monitoring technologies. The device called bioflux is for use by caregivers in a clinical setting, remotely transmitting detailed information about the heart’s functioning which can then be analyzed by caregivers. The device known as biolife serves individuals outside of a clinical setting, largely doing the same chore. The advantage of the technology is mobility, without sacrificing accuracy.

    The device furthest along the development path is bioflux. The company recently filed a 510k request with the FDA for its bioflux technology (the 510k path is for medical devices rather than drugs, and as such doesn’t require a lot of regulatory deliberation), and has heard back from the FDA about a key part of the device already – it got the green light. Another arm of the FDA must look at other aspects of the device.

    The two devices utilize the same basic technology, but are clearly addressing different markets.

    It must also be noted that the ECG monitoring software found in a bioflux has been approved by the FDA in the past and is already rather standard technology for ECG monitoring equipment in hospitals and

Top Medical Stocks To Buy For 2018: Merrimack Pharmaceuticals, Inc.(MACK)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Paul Ausick]

    Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) dropped nearly 11% on Tuesday to post a new 52-week low of $3.30 after closing at $3.67 on Monday. Volume was more than 3 times the daily average of about 3.7 million shares. The stock’s 52-week high is $9.02 The company said Tuesday that it has sold some of its cancer drugs to Ipsen for $1 billion.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million.
    Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter.
    Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss.
    Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering.
    Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday.
    Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday.
    Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results.
    Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday.
    Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report.
    GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading.
    Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market

Top Medical Stocks To Buy For 2018: L.B. Foster Company(FSTR)

Advisors’ Opinion:

  • [By Lee Jackson]

    The L.B. Foster Co. (NASDAQ: FSTR) had one of itsdirectors adding to a position last week. Legion Partners bought 72,301 shares of the transportation and energy infrastructure company at prices between $12.27 and $13.07. The total for the purchase came in right at $1 million. The shares closed Friday at $13.30, in a 52-week range of$9.25 to $20.77. The consensus price target is $15.00.

  • [By Lisa Levin]

    Friday afternoon, the basic materials sector proved to be a source of strength for the market. Leading the sector was strength from Intrepid Potash, Inc. (NYSE: IPI) and L.B. Foster Co (NASDAQ: FSTR).

  • [By Lisa Levin]

    Wednesday afternoon, basic materials shares gained by 1.74 percent. Meanwhile, top gainers in the sector included Intrepid Potash, Inc. (NYSE: IPI), and L.B. Foster Co (NASDAQ: FSTR).

Top Medical Stocks To Buy For 2018: American Express Company(AXP)

Advisors’ Opinion:

  • [By Paul Ausick]

    American Express Co. (NYSE: AXP) traded up 0.57% at $88.70. The stock’s 52-week range is $59.50 to $89.38. Volume was about half the daily average of around 3.2 million. The company had no specific news Tuesday.

  • [By Cooper Creagan]

    Since then, the money spent using prepaid cards has nearly doubled, as big players like Wal-Mart Stores Inc. (NYSE: WMT) and American Express Co. (NYSE: AXP) have entered the game with the prepaid Bluebird card.

  • [By Garrett Baldwin]

    The Ripple coin topped $0.23 after a 10% surge during Thursday trading. The price surged after credit card giant American Express Co. (NYSE: AXP) announced it has established a payments corridor between the United States and the United Kingdom using Ripple’s technology.

  • [By Paul Ausick]

    American Express Co. (NYSE: AXP) traded up 1.41% at $99.36. The stock’s 52-week range is $75.51 to $102.39. Volume was about 10% above the daily average of around 3.4 million shares. The company had no news Wednesday.

  • [By Chris Lange]

    American Express Co. (NYSE: AXP) will share its latest quarterly earnings on Wednesday. The consensus estimates call for $1.48 in EPS and $8.29 billion in revenue. Shares ended last week at $92.86, in a 52-week range of $59.78 to $92.92. The consensus analyst target is $89.91.

  • [By Paul Ausick]

    American Express Co. (NYSE: AXP) traded down 0.64% at $73.89. The stock’s 52-week range is $50.27 to $75.74. Volume was less than half the daily average of around 4.7 million shares. The company had no specific news.